GYY4137 exhibits anti-atherosclerosis effect in apolipoprotein E (-/-) mice via PI3K/Akt and TLR4 signalling.

Clinical and Experimental Pharmacology & Physiology
Yaofu ZhengJumei Yan

Abstract

Hydrogen sulphide (H2 S) had been suggested to be involved in the pathogenesis of atherosclerosis, but the underlying molecular mechanisms are poorly understood. In this study, we aimed to investigate the anti-atherosclerosis effect of morpholin-4-ium-methoxyphenyl-morpholino-phosphinodithioate (GYY4137) in RAW264.7 cell-derived foam cells formation and in the atherosclerotic plaque of ApoE-/- mice fed with a high-fat diet, and study the underlying mechanisms of phosphatidylinositol 3-kinase (PI3K), serine/ threonine kinase (Akt) and Toll-like receptor 4 (TLR4) signalling pathway. In the ApoE-/- mice fed with a high-fat diet, daily GYY4137 administration for 8 weeks effectively decreased carotid atherosclerotic plaque area and the volume of foam cells, regulated the lipid metabolism, down-regulated the pro-inflammatory cytokine levels and up-regulated the anti-inflammatory cytokines levels. Consistent with these findings, in the RAW264.7 cell-derived foam cells, GYY4137 ameliorated foam cell formation in vitro, and decreased the expression of pro-inflammatory cytokines. Furthermore, our studies showed that GYY4137 could activate the PI3K/Akt signalling pathway and consequently reduce the expression of TLR4 to be critical for fo...Continue Reading

References

Jan 14, 1999·The New England Journal of Medicine·R Ross
Aug 8, 2006·Immunologic Research·Adam E MullickLinda K Curtiss
Oct 20, 2007·Nature Reviews. Drug Discovery·Csaba Szabó
Jun 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bertrand CalippePierre Gourdy
Nov 8, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Yanfei WangJunbao Du
Dec 5, 2009·Nature Reviews. Immunology·Ira Tabas
Jan 28, 2010·Cell Biochemistry and Function·David J ElseyGary F Baxter
Oct 23, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Mie HigashimoriDebbie Beasley
Feb 16, 2011·Experimental Biology and Medicine·Zhan-Zhi ZhaoZhi-Sheng Jiang
May 3, 2011·Cell·Kathryn J Moore, Ira Tabas
Sep 17, 2011·The Journal of Surgical Research·Kenneth W HowellJoseph C Cleveland
Mar 20, 2012·Biochemical and Biophysical Research Communications·So Young KimJoo Young Lee
Jul 8, 2014·Journal of Atherosclerosis and Thrombosis·Xiaolei ZhangJinchuan Yan
Jul 26, 2014·Nature Reviews. Immunology·Nicholas J GayClare E Bryant
Oct 24, 2015·Journal of Cellular and Molecular Medicine·Dimitry A ChistiakovAlexander N Orekhov
Jul 6, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Qutuba G KarwiGary F Baxter
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yan LinEnqi Liu

❮ Previous
Next ❯

Citations

Mar 7, 2021·International Journal of Molecular Sciences·Yi-Zhen WangDong-Dong Wu
Mar 27, 2021·Frontiers in Pharmacology·Yunyun ZhaoZhongqun Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.